GO:0002768 immune response-regulating cell surface receptor signaling pathway: Signaling Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002768 describes the series of molecular signals initiated by an extracellular ligand binding to a cell surface receptor that can activate, perpetuate, or inhibit an immune response.
• The term covers both activating and inhibitory receptor pathways, including TLR, BCR, complement receptor, and decoy receptor signaling.
• Core signaling modules include TLR2/MyD88/NF-kB, TLR4/NF-kB, BCR antigen recognition, and osteoprotegerin-mediated decoy regulation.
• Dysregulation of this pathway is linked to mycobacterial infection, Francisella tularensis entry, clear cell renal cell carcinoma, testicular cancer, and inflammatory diseases.
• Key research methods include CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, proteomics, and immune cell infiltration analysis.
• EDITGENE provides CRISPR cell model services to dissect causal roles of genes in GO:0002768 signaling.
Description
GO:0002768, immune response-regulating cell surface receptor signaling pathway, is a biological process Gene Ontology term that defines the molecular signals initiated when an extracellular ligand binds to a receptor on the surface of a target cell and is capable of activating, perpetuating, or inhibiting an immune response. This term is central to immunology because it captures the first decisive step in immune sensing: how a cell converts an external cue into an intracellular signal that shapes inflammation, pathogen control, or tolerance. The pathway is not limited to classical immune cells; it operates in epithelial, endothelial, and stromal compartments, where receptor signaling can amplify or restrain immune reactions. Researchers study GO:0002768 because its components are frequent therapeutic targets and biomarkers. For example, TLR2-mediated signaling is a major axis in mycobacterial infection control, and TLR4/NF-kB signaling links metabolic stress to hepatic inflammation. B cell receptor and complement receptor pathways govern pathogen entry into B cells, while decoy receptors such as osteoprotegerin can modulate immune function by sequestering ligands. In cancer, immune cell infiltration signatures associated with chemokine axes such as CXCL13 are used to infer pathway activity in clear cell renal cell carcinoma. Because the term spans multiple receptor families and cell types, precise experimental models are required to determine whether a candidate gene is causally involved in immune response-regulating signaling. This article integrates the QuickGO definition with verified PubMed literature to outline the mechanism, key genes, disease links, and research methods for GO:0002768.
immune response-regulating cell surface receptor signaling pathway At A Glance
| GO ID | GO:0002768 |
|---|---|
| GO term | immune response-regulating cell surface receptor signaling pathway |
| Ontology | biological_process |
| Synonym | immune response-regulating cell surface receptor signalling pathway |
| Definition | The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell capable of activating, perpetuating, or inhibiting an immune response. |
| Major function | Transduces extracellular immune cues into intracellular signals that activate, sustain, or inhibit immune responses. |
| Receptor classes involved | Toll-like receptors, B cell receptors, complement receptors, decoy receptors such as osteoprotegerin. |
| Representative ligands | Pathogen-associated molecular patterns, antigens, complement fragments, cytokines, and serum-borne lipids. |
| Downstream modules | NF-kB, MAPK, PI3K-AKT, and inflammasome-associated signaling. |
What Is GO:0002768?
GO:0002768 is defined as the series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell that is capable of activating, perpetuating, or inhibiting an immune response. In simpler terms, it is the cell surface receptor-to-intracellular signaling process that decides whether an immune reaction starts, continues, or stops. The term includes signaling from receptors such as Toll-like receptors, B cell receptors, complement receptors, and decoy receptors, and it encompasses both pro-inflammatory and regulatory outcomes.
Why Is immune response-regulating cell surface receptor signaling pathway Important in Cell Biology?
GO:0002768 is important because it defines the entry point for immune decision-making at the cell surface, and its dysregulation contributes to infectious disease, chronic inflammation, autoimmunity, and cancer. Understanding this term helps researchers interpret how receptor-ligand interactions translate into immune outcomes and how to target them experimentally or therapeutically.
• Defines the first step of immune sensing at the cell surface, linking extracellular ligands to intracellular signaling.
• Covers both activating and inhibitory outcomes, making it central to immune homeostasis.
• TLR2 signaling is a key axis for mycobacterium infection control.
• TLR4/NF-kB signaling connects metabolic stress and serum-borne lipids to amplified inflammatory responses.
• B cell receptor and complement receptor pathways regulate pathogen entry into B cells.
• Decoy receptor osteoprotegerin modulates immune function by intercepting ligands.
• Immune cell infiltration signatures in clear cell renal cell carcinoma are associated with chemokine axes such as CXCL13.
• Testicular cancer microenvironment studies use immune scores to identify novel genes in this pathway.
• Provides a framework for CRISPR-based causal gene validation in immune signaling.
• Supports biomarker and drug target discovery across infectious, inflammatory, and malignant diseases.
What Happens During immune response-regulating cell surface receptor signaling pathway?
Ligand recognition and receptor engagement
In simple terms: An external signal molecule binds to a receptor on the cell surface, like a key fitting a lock.
The pathway begins when an extracellular ligand, such as a pathogen-associated molecular pattern, antigen, complement fragment, or serum-borne lipid, binds to a cell surface receptor. This binding event is the initiating step that determines whether the cell will mount, sustain, or inhibit an immune response. Receptor engagement can occur on classical immune cells as well as on epithelial and stromal cells, broadening the impact of the signal.
Receptor-proximal signaling and adaptor recruitment
In simple terms: The activated receptor recruits helper proteins inside the cell to pass the message along.
Upon ligand binding, receptors such as TLR2 and TLR4 recruit adaptor proteins to propagate the signal. In B cells, B cell receptor and complement receptor engagement triggers receptor-proximal signaling that can facilitate pathogen entry. Decoy receptors such as osteoprotegerin can intercept ligands and modulate the strength or duration of the signal.
Activation of NF-kB and inflammatory transcription
In simple terms: The signal reaches the nucleus and switches on genes that drive inflammation.
A major downstream module of GO:0002768 is the NF-kB pathway. TLR4/NF-kB signaling is inhibited by synbiotic intervention in obesity models, demonstrating that this axis is modifiable and metabolically relevant. Serum-borne lipids can amplify TLR-activated inflammatory responses, showing that the lipid environment tunes the output of this pathway. TLR2-mediated signaling similarly converges on inflammatory gene programs relevant to mycobacterial infection control.
Immune cell recruitment and infiltration
In simple terms: The signal calls immune cells into the tissue, changing the local immune landscape.
Activation of immune response-regulating receptors can reshape the immune cell infiltration signature of a tissue. In clear cell renal cell carcinoma, CXCL13 expression is associated with immune cell infiltration, reflecting chemokine-driven recruitment downstream of receptor signaling. In testicular cancer, ESTIMATE algorithm-derived immune scores have been used to identify novel genes in the tumor microenvironment, linking receptor signaling to immune composition.
Inhibitory and decoy regulation
In simple terms: Some receptors or decoy molecules put the brakes on the immune signal.
GO:0002768 explicitly includes signaling capable of inhibiting an immune response. Osteoprotegerin functions as a decoy receptor with immune-modulatory activity, illustrating how soluble decoys can neutralize ligands and dampen signaling. This inhibitory arm is essential for preventing excessive inflammation and for maintaining immune homeostasis.
Key Genes Involved in GO:0002768 immune response-regulating cell surface receptor signaling pathway
The following genes and proteins are experimentally implicated in GO:0002768 signaling based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR2 | Recognizes pathogen-associated molecular patterns and initiates inflammatory signaling | Central to mycobacterium infection control |
| TLR4 | Transduces lipid and pathogen signals to NF-kB | Target of synbiotic inhibition in obesity models |
| MYD88 | Adaptor protein for TLR signaling | Core node in TLR2-mediated signaling networks |
| NFKB1 | Transcription factor driving inflammatory gene expression | Downstream effector of TLR4/NF-kB signaling |
| BCR | B cell receptor that recognizes antigen | Mediates Francisella tularensis entry into B cells |
| CR1 | Complement receptor involved in pathogen recognition | Facilitates pathogen entry into B cells |
| TNFRSF11B | Encodes osteoprotegerin, a decoy receptor | Modulates immune function by intercepting ligands |
| CXCL13 | Chemokine recruiting immune cells | Associated with immune cell infiltration in clear cell renal cell carcinoma |
| EGR1 | Transcription factor linked to inflammatory and neurovascular signatures | Suggested link between migraine and ischemic stroke |
| IL6 | Pro-inflammatory cytokine | Amplified by serum-borne lipids in TLR-activated responses |
| TNF | Pro-inflammatory cytokine | Part of TLR-activated inflammatory output |
| CCL2 | Chemokine recruiting monocytes | Downstream of inflammatory receptor signaling |
| CD14 | Co-receptor for TLR4 | Participates in lipid-amplified TLR responses |
| LY96 | MD-2 co-receptor for TLR4 | Required for TLR4 ligand sensing |
| TICAM1 | TRIF adaptor for TLR4 | Alternative adaptor in TLR4 signaling |
| TRAF6 | E3 ubiquitin ligase in TLR/IL-1R signaling | Propagates NF-kB activation |
| MAP3K7 | TAK1 kinase activating NF-kB and MAPK | Central kinase node in TLR signaling |
| NFKBIA | Inhibitor of NF-kB | Feedback regulator of inflammatory signaling |
How Is immune response-regulating cell surface receptor signaling pathway Regulated?
GO:0002768 signaling is regulated at multiple levels. Serum-borne lipids can amplify TLR-activated inflammatory responses, indicating that the lipid microenvironment modulates signal strength. The NF-kB arm is subject to feedback inhibition, as shown by synbiotic-mediated inhibition of hepatic TLR4/NF-kB signaling in obesity models. Decoy receptors such as osteoprotegerin provide an extracellular braking mechanism by sequestering ligands. In addition, transcription factors such as EGR1 are associated with inflammatory and neurovascular signatures, suggesting downstream transcriptional regulation of this pathway.
immune response-regulating cell surface receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR2 | Mycobacterium infection | TLR2 knockout macrophages and infection challenge |
| TLR4 | Obesity-associated hepatic inflammation | TLR4 knockout hepatocytes and synbiotic treatment |
| CXCL13 | Clear cell renal cell carcinoma immune infiltration | CXCL13 overexpression in renal cancer cell lines |
| TNFRSF11B | Immune modulation by decoy receptor | Osteoprotegerin knockout or overexpression models |
| BCR/CR1 | Francisella tularensis B cell entry | B cell receptor and complement receptor knockout B cells |
Infectious disease and pathogen entry
GO:0002768 is directly implicated in host-pathogen interactions. TLR2-mediated signaling is a major axis for mycobacterium infection control, and understanding its network can guide better infection control strategies. Francisella tularensis entry into murine B cells depends on B cell receptors and complement receptors, demonstrating how pathogens exploit immune response-regulating receptors for cellular entry.
Cancer and the tumor immune microenvironment
In clear cell renal cell carcinoma, CXCL13 expression is associated with immune cell infiltration signatures, linking chemokine-driven receptor signaling to tumor immunobiology. In testicular cancer, ESTIMATE algorithm-derived immune scores have been used to identify novel genes in the tumor microenvironment, highlighting the relevance of immune response-regulating pathways to cancer biology.
Metabolic and inflammatory disease
TLR4/NF-kB signaling connects metabolic stress to hepatic inflammation, and synbiotic intervention can alleviate obesity by inhibiting this pathway. Serum-borne lipids can amplify TLR-activated inflammatory responses, suggesting that dyslipidemia may exacerbate inflammatory signaling through GO:0002768. EGR1-associated inflammatory and neurovascular signatures suggest a potential link between migraine and ischemic stroke, implicating this pathway in neurovascular disease.
Immune regulation and decoy receptor biology
Osteoprotegerin functions as a decoy receptor with immune-modulatory activity, illustrating how dysregulation of inhibitory arms of GO:0002768 can contribute to immune dysfunction. This highlights the importance of balance between activating and inhibitory receptor signaling in disease.
From immune response-regulating cell surface receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TLR2 required for mycobacterial control? | TLR2 knockout macrophage cell line |
| Does TLR4 mediate lipid-amplified inflammation? | TLR4 knockout hepatocyte cell line |
| Does CXCL13 drive immune infiltration in ccRCC? | CXCL13 overexpression in renal carcinoma cells |
| Is osteoprotegerin a functional decoy receptor? | TNFRSF11B knockout or overexpression cells |
| Does BCR mediate Francisella entry? | BCR knockout B cell line |
| Does EGR1 regulate inflammatory neurovascular signatures? | EGR1 knockout endothelial or neuronal cells |
How to Study the immune response-regulating cell surface receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptional changes | Identify NF-kB and chemokine targets downstream of receptor activation |
| Phosphoproteomics | Kinase activation and signaling nodes | Map TLR2/TLR4 signaling cascades |
| ESTIMATE immune scoring | Immune cell infiltration from expression data | Tumor microenvironment analysis in testicular cancer |
| Chemokine correlation analysis | Association of chemokines with immune infiltration | Clear cell renal cell carcinoma studies |
| Pathogen entry assay | Pathogen internalization into immune cells | Francisella tularensis B cell entry |
| Ligand stimulation assay | Inflammatory cytokine output | Serum-borne lipid amplification of TLR responses |
| CRISPR knockout | Loss-of-function phenotype | Test causal role of TLR2, TLR4, BCR |
| Overexpression | Gain-of-function phenotype | Test CXCL13 or osteoprotegerin effects |
Transcriptomic profiling of receptor signaling
RNA-seq can measure global transcriptional changes downstream of GO:0002768 activation, including NF-kB target genes and chemokines. In cancer, immune score algorithms applied to transcriptomic data can identify novel genes associated with immune cell infiltration.
Proteomic and phosphoproteomic analysis
Proteomics can quantify receptor-proximal signaling complexes and post-translational modifications. Phosphoproteomics is particularly useful for mapping kinase cascades such as TAK1 and NF-kB activation downstream of TLR engagement.
Immune cell infiltration and microenvironment analysis
ESTIMATE and related algorithms derive immune scores from expression data to infer the immune composition of tissues, as demonstrated in testicular cancer. Chemokine signatures such as CXCL13 can be correlated with immune cell infiltration in clear cell renal cell carcinoma.
Functional infection and ligand challenge assays
Pathogen challenge assays, such as Francisella tularensis entry into B cells, directly test the role of B cell receptors and complement receptors in GO:0002768 signaling. Ligand stimulation with pathogen-associated molecular patterns or serum-borne lipids can quantify inflammatory output.
How CRISPR Can Be Used to Study GO:0002768 immune response-regulating cell surface receptor signaling pathway
Knockout
CRISPR knockout of genes such as TLR2, TLR4, or BCR can determine whether they are required for immune response-regulating signaling. For example, TLR2 knockout models are used to study mycobacterium infection control, and TLR4 knockout models test lipid-amplified inflammation.
Point Mutation
Point mutation knock-in can dissect specific residues required for receptor signaling, such as phosphorylation sites in adaptor proteins or ligand-binding residues in decoy receptors like osteoprotegerin. This approach refines causal claims beyond simple loss-of-function.
Knock-in
Knock-in of tagged or reporter alleles allows tracking of receptor signaling components in live cells. Tagged knock-in of TLR4 or BCR can reveal trafficking and interaction dynamics during immune activation.
Overexpression
Overexpression of chemokines such as CXCL13 or decoy receptors such as osteoprotegerin can test gain-of-function effects on immune infiltration and signaling output. This is useful when the gene is a candidate driver of immune microenvironment remodeling.
How EDITGENE Supports immune response-regulating cell surface receptor signaling pathway Research
Researchers studying immune response-regulating cell surface receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, immune activation, or disease progression. EDITGENE provides CRISPR-based cell model services to enable precise, reproducible experiments for GO:0002768 research.
Contact EDITGENE today to design your custom CRISPR model for immune response-regulating cell surface receptor signaling pathway research.
Frequently Asked Questions About immune response-regulating cell surface receptor signaling pathway
What is GO:0002768?
GO:0002768 is the Gene Ontology term for immune response-regulating cell surface receptor signaling pathway, defined as the series of molecular signals initiated by an extracellular ligand binding to a cell surface receptor that can activate, perpetuate, or inhibit an immune response.
What genes are involved in immune response-regulating cell surface receptor signaling pathway?
Key genes include TLR2, TLR4, MYD88, NFKB1, BCR, CR1, TNFRSF11B, CXCL13, and EGR1, based on published studies.
What is the function of GO:0002768?
Its function is to transduce extracellular immune cues into intracellular signals that determine whether an immune response is activated, sustained, or inhibited.
How is immune response-regulating cell surface receptor signaling pathway regulated?
It is regulated by ligand availability, serum-borne lipids, decoy receptors such as osteoprotegerin, and feedback inhibition of NF-kB signaling.
What diseases are linked to GO:0002768?
It is linked to mycobacterial infection, Francisella tularensis entry, clear cell renal cell carcinoma, testicular cancer, obesity-associated inflammation, and neurovascular disease.
What is the role of TLR2 in this pathway?
TLR2 mediates signaling networks important for mycobacterium infection control.
How does TLR4/NF-kB signaling relate to GO:0002768?
TLR4/NF-kB is a major downstream module of GO:0002768, and its inhibition by synbiotics alleviates obesity-associated hepatic inflammation.
What is the role of osteoprotegerin in immune signaling?
Osteoprotegerin is a decoy receptor with immune-modulatory function that can intercept ligands and modulate immune responses.
How can CRISPR be used to study GO:0002768?
CRISPR knockout, point mutation, knock-in, and overexpression models can test causal roles of receptors, adaptors, and chemokines in this pathway.
What methods are used to study immune response-regulating receptor signaling?
Common methods include RNA-seq, phosphoproteomics, immune score analysis, chemokine correlation, pathogen entry assays, and ligand stimulation assays.
Conclusion
GO:0002768, immune response-regulating cell surface receptor signaling pathway, is a foundational biological process that converts extracellular immune cues into intracellular signals capable of activating, perpetuating, or inhibiting immune responses. Its components are implicated in infectious disease, cancer, metabolic inflammation, and neurovascular disease, making it a high-value target for mechanistic and translational research. By combining the QuickGO definition with verified PubMed evidence, researchers can design rigorous CRISPR-based experiments to determine causal gene roles in this pathway. EDITGENE supports these efforts with knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to immune signaling research.
References
- 1. Sharma N et al.. 2021. Serum-borne lipids amplify TLR-activated inflammatory responses.. J Leukoc Biol 109(4):821-831 PMID: 32717772
- 2. Rong W et al.. 2026. EGR1-associated inflammatory and neurovascular signatures suggest a potential link between migraine and ischemic stroke.. J Headache Pain PMID: 42432497
- 3. Yu X et al.. 2014. Navigating through the maze of TLR2 mediated signaling network for better mycobacterium infection control.. Biochimie 102:1-8 PMID: 24594065
- 4. Jiao F et al.. 2020. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.. Int J Med Sci 17(11):1610-1624 PMID: 32669964
- 5. Bengtsson AK et al.. 2002. Immune function of the decoy receptor osteoprotegerin.. Crit Rev Immunol 22(3):201-15 PMID: 12498383
- 6. Kang Y et al.. 2023. A Newly Synbiotic Combination Alleviates Obesity by Modulating the Gut Microbiota-Fat Axis and Inhibiting the Hepatic TLR4/NF-κB Signaling Pathway.. Mol Nutr Food Res 67(24):e2300141 PMID: 37594720
- 7. Ke ZB et al.. 2021. Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores.. J Cell Physiol 236(1):706-713 PMID: 32617980
- 8. Plzakova L et al.. 2015. Entry of Francisella tularensis into Murine B Cells: The Role of B Cell Receptors and Complement Receptors.. PLoS One 10(7):e0132571 PMID: 26161475
